Zhejiang Haisen Pharmaceutical Past Earnings Performance
Past criteria checks 4/6
Zhejiang Haisen Pharmaceutical has been growing earnings at an average annual rate of 10.5%, while the Pharmaceuticals industry saw earnings growing at 9.2% annually. Revenues have been declining at an average rate of 4.2% per year. Zhejiang Haisen Pharmaceutical's return on equity is 8.8%, and it has net margins of 27.8%.
Key information
10.5%
Earnings growth rate
5.8%
EPS growth rate
| Pharmaceuticals Industry Growth | 10.9% |
| Revenue growth rate | -4.2% |
| Return on equity | 8.8% |
| Net Margin | 27.8% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How Zhejiang Haisen Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 406 | 113 | 36 | 20 |
| 31 Dec 23 | 397 | 105 | 36 | 19 |
| 30 Sep 23 | 390 | 97 | 35 | 19 |
| 30 Jun 23 | 405 | 97 | 34 | 18 |
| 31 Mar 23 | 424 | 104 | 31 | 16 |
| 01 Jan 23 | 423 | 108 | 33 | 16 |
| 30 Sep 22 | 417 | 108 | 34 | 12 |
| 30 Jun 22 | 414 | 107 | 36 | 11 |
| 31 Mar 22 | 401 | 101 | 34 | 11 |
| 31 Dec 21 | 389 | 94 | 33 | 12 |
| 31 Dec 20 | 285 | 63 | 27 | 11 |
| 31 Dec 19 | 266 | 69 | 43 | 9 |
| 31 Dec 18 | 247 | 59 | 42 | 9 |
Quality Earnings: 001367 has high quality earnings.
Growing Profit Margin: 001367's current net profit margins (27.8%) are higher than last year (24.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 001367's earnings have grown by 10.5% per year over the past 5 years.
Accelerating Growth: 001367's earnings growth over the past year (8.5%) is below its 5-year average (10.5% per year).
Earnings vs Industry: 001367 earnings growth over the past year (8.5%) exceeded the Pharmaceuticals industry -1.1%.
Return on Equity
High ROE: 001367's Return on Equity (8.8%) is considered low.